252 related articles for article (PubMed ID: 31830575)
21. Nanosponges encapsulating dexamethasone for ocular delivery: formulation design, physicochemical characterization, safety and corneal permeability assessment.
Swaminathan S; Vavia PR; Trotta F; Cavalli R
J Biomed Nanotechnol; 2013 Jun; 9(6):998-1007. PubMed ID: 23858964
[TBL] [Abstract][Full Text] [Related]
22. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
23. Insulin-loaded mucoadhesive nanoparticles based on mucin-chitosan complexes for oral delivery and diabetes treatment.
Mumuni MA; Kenechukwu FC; Ofokansi KC; Attama AA; Díaz DD
Carbohydr Polym; 2020 Feb; 229():115506. PubMed ID: 31826394
[TBL] [Abstract][Full Text] [Related]
24. Ocular anti-inflammatory activity of prednisolone acetate loaded chitosan-deoxycholate self-assembled nanoparticles.
Hanafy AF; Abdalla AM; Guda TK; Gabr KE; Royall PG; Alqurshi A
Int J Nanomedicine; 2019; 14():3679-3689. PubMed ID: 31239660
[No Abstract] [Full Text] [Related]
25. A Nanoparticle-Based Ophthalmic Formulation of Dexamethasone Enhances Corneal Permeability of the Drug and Prolongs Its Corneal Residence Time.
Nagai N; Nakazawa Y; Ito Y; Kanai K; Okamoto N; Shimomura Y
Biol Pharm Bull; 2017; 40(7):1055-1062. PubMed ID: 28674248
[TBL] [Abstract][Full Text] [Related]
26. Multifunctional properties of organic-inorganic hybrid nanocomposites based on chitosan derivatives and layered double hydroxides for ocular drug delivery.
Xu T; Zhang J; Chi H; Cao F
Acta Biomater; 2016 May; 36():152-63. PubMed ID: 26940970
[TBL] [Abstract][Full Text] [Related]
27. Multifunctional carboxymethyl chitosan derivatives-layered double hydroxide hybrid nanocomposites for efficient drug delivery to the posterior segment of the eye.
Wang Y; Zhou L; Fang L; Cao F
Acta Biomater; 2020 Mar; 104():104-114. PubMed ID: 31931169
[TBL] [Abstract][Full Text] [Related]
28. Preparation and characterization of a pterostilbene-peptide prodrug nanomedicine for the management of dry eye.
Hu L; Hu Z; Yu Y; Ding X; Li K; Gong Q; Lin D; Dai M; Lu F; Li X
Int J Pharm; 2020 Oct; 588():119683. PubMed ID: 32712251
[TBL] [Abstract][Full Text] [Related]
29. Trimethyl chitosan nanoparticles for ocular baicalein delivery: Preparation, optimization, in vitro evaluation, in vivo pharmacokinetic study and molecular dynamics simulation.
Li J; Jin X; Yang Y; Zhang L; Liu R; Li Z
Int J Biol Macromol; 2020 Aug; 156():749-761. PubMed ID: 32320806
[TBL] [Abstract][Full Text] [Related]
30. Betaxolol hydrochloride loaded chitosan nanoparticles for ocular delivery and their anti-glaucoma efficacy.
Jain K; Kumar RS; Sood S; Dhyanandhan G
Curr Drug Deliv; 2013 Oct; 10(5):493-9. PubMed ID: 23410069
[TBL] [Abstract][Full Text] [Related]
31. Amphotericin-B entrapped lecithin/chitosan nanoparticles for prolonged ocular application.
Chhonker YS; Prasad YD; Chandasana H; Vishvkarma A; Mitra K; Shukla PK; Bhatta RS
Int J Biol Macromol; 2015 Jan; 72():1451-8. PubMed ID: 25453292
[TBL] [Abstract][Full Text] [Related]
32. Self-assembled nanoparticles of modified-chitosan conjugates for the sustained release of DL-α-tocopherol.
Quiñones JP; Gothelf KV; Kjems J; Yang C; Caballero AM; Schmidt C; Covas CP
Carbohydr Polym; 2013 Jan; 92(1):856-64. PubMed ID: 23218376
[TBL] [Abstract][Full Text] [Related]
33. Cross-linked chitosan in nano and bead scales as drug carriers for betamethasone and tetracycline.
Taghizadeh MT; Ashassi-Sorkhabi H; Afkari R; Kazempour A
Int J Biol Macromol; 2019 Jun; 131():581-588. PubMed ID: 30885730
[TBL] [Abstract][Full Text] [Related]
34. Preparation of Chitosan Okra Nanoparticles: Optimization and Evaluation as Mucoadhesive Drug Delivery System.
Brar V; Kaur G
Pharm Nanotechnol; 2018; 6(3):180-191. PubMed ID: 30101724
[TBL] [Abstract][Full Text] [Related]
35. Directing the nanoparticle formation by the combination with small molecular assembly and polymeric assembly for topical suppression of ocular inflammation.
Huang J; Yu X; Zhou Y; Zhang R; Song Q; Wang Q; Li X
Int J Pharm; 2018 Nov; 551(1-2):223-231. PubMed ID: 30213683
[TBL] [Abstract][Full Text] [Related]
36. Methyl-β-cyclodextrin quaternary ammonium chitosan conjugate: nanoparticles vs macromolecular soluble complex.
Piras AM; Fabiano A; Chiellini F; Zambito Y
Int J Nanomedicine; 2018; 13():2531-2541. PubMed ID: 29731628
[TBL] [Abstract][Full Text] [Related]
37. Liposomal dexamethasone-moxifloxacin nanoparticle combinations with collagen/gelatin/alginate hydrogel for corneal infection treatment and wound healing.
Chang MC; Kuo YJ; Hung KH; Peng CL; Chen KY; Yeh LK
Biomed Mater; 2020 Aug; 15(5):055022. PubMed ID: 32434164
[TBL] [Abstract][Full Text] [Related]
38. Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.
Silva MM; Calado R; Marto J; Bettencourt A; Almeida AJ; Gonçalves LMD
Mar Drugs; 2017 Dec; 15(12):. PubMed ID: 29194378
[TBL] [Abstract][Full Text] [Related]
39. Mucoadhesive dexamethasone acetate-polymyxin B sulfate cationic ocular nanoemulsion--novel combinatorial formulation concept.
Li X; Müller RH; Keck CM; Bou-Chacra NA
Pharmazie; 2016 Jun; 71(6):327-33. PubMed ID: 27455551
[TBL] [Abstract][Full Text] [Related]
40. Preparation and evaluation of biopolymeric nanoparticles as drug delivery system in effective treatment of rheumatoid arthritis.
Kumar V; Leekha A; Tyagi A; Kaul A; Mishra AK; Verma AK
Pharm Res; 2017 Mar; 34(3):654-667. PubMed ID: 28097508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
